Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Bhuiyan MNH, et al
Etiology Genetics COL5A1 or COL5A2 mutation in 40-50% less common mutations identified below Associated conditions Connective tissue disorder characterized by hyperelastic/fragile skin joint hypermobility and dislocation generalized ligamentous laxity poor wound healing early onset arthritis additional features Classification Berlin Classification (1988) - revised Types I - XI exist Types II and III - most common and least disabling Villefranche Classification (1998) Presentation Symptoms double-jointedness easily damaged, bruised, & stretchy skin easy scarring & poor wound healing increased joint mobility, joint popping, early arthritis especially shoulders, patellae, ankles chronic musculoskeletal pain (50%) Physical exam a score of 5 or more on 9-point Beighton-Horan scale defines joint hypermobility
X
We also offer in-office injections at our Nashville and Memphis locations for those who prefer professional administration
GLP-1 metabolite GLP-1(9-36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion
Witschi, A., Reddy, S., Stofer, B
US$ 27.72
US$ 22.34
US$ 24.19
US$ 23.84
US$ 26.51
US$ 22.31
US$ 23.18
US$ 27.50
US$ 24.32
US$ 29.30
US$ 27.69
US$ 28.27
US$ 20.93
US$ 26.93
US$ 27.95
